key: cord-0902632-rybknv5c
authors: Pati, Ilaria; Velati, Claudio; Mengoli, Carlo; Franchini, Massimo; Masiello, Francesca; Marano, Giuseppe; Veropalumbo, Eva; Vaglio, Stefania; Piccinini, Vanessa; Pupella, Simonetta; Liumbruno, Giancarlo M.
title: A forecasting model to estimate the drop in blood supplies during the SARS‐CoV‐2 pandemic in Italy
date: 2021-03-10
journal: Transfus Med
DOI: 10.1111/tme.12764
sha: 72d26dcc221d59f87434cf4a9cecf2bb5834c6fa
doc_id: 902632
cord_uid: rybknv5c

OBJECTIVES: To estimate the number of actually Severe acute respiratory syndrome Coronavirus‐2 (SARS‐CoV‐2) infected blood donors applying a statistical forecasting model. BACKGROUND: Following the outbreak of the SARS‐CoV‐2 epidemic, a drop in blood donation has been observed. It is crucial to determine the actual number of potential SARS‐CoV‐2‐positive donors to define the measures and ensure adequate blood supply. METHODS: The cumulative incidence of SARS‐CoV‐2 positivity, calculated on the general population, was applied to the donor population by estimating the number of positive subjects. The calculation model was validated by the linear interpolation method. The number of blood units actually discarded based on post‐donation information was also taken into account. RESULTS: Three months after the outbreak, 5322 donors were estimated to be positive for SARS‐CoV‐2 and were therefore potentially excluded from donation. A total of units of blood components were discarded following post donation information. The estimated number of donors deceased (180) and the number of clinically recovered individuals in the same period was also considered. CONCLUSION: This forecasting model can be used to obtain information on blood donors' involvement during future SARS‐CoV‐2 outbreaks, especially in case of changes concerning epidemiology, incidence by age bracket and geographical distribution and also for new outbreaks of emerging viruses.

On 30 January 2020, the World Health Organization (WHO) declared the epidemic a Public Health Emergency of International Concern, and on the 11th March the WHO made the assessment that COVID-19 could be characterised as a pandemic. 1, 2 The spread of the new disease had an initial impact on blood and blood component donations, causing a significant reduction in donations in China and in the other countries affected by the epidemic.

The reason for this reduction was probably related to logistics (transfer becoming more difficult as a consequence of lockdown measures adopted) and, above all, to blood donors' fear of contracting the infection in blood donation centres. [3] [4] [5] [6] In Italy, after an initial drop in donations in the first 10 days of March 2020, the pace stepped up because of among other things, the introductions of new national measures aimed at reassuring blood donors and guaranteeing adequate organisational conditions. 7 Based on the unlikely transmission of SARS-CoV-2 through labile blood components, 8 Therefore, during the first phase, the pandemic had a very strong impact on the national health system's ability to respond, particularly with regard to intensive care and resuscitation units. However, overall, the level of self-sufficiency in blood and blood components was not overly affected because, at the same time, hospitals greatly reduced their non-urgent medical and surgical activities. 7 With the gradual exit from the state of emergency and the lifting of lockdown restrictions, hospitals will restart their routine activities, and the demand for blood components will return to pre-pandemic levels. 

The duration considered for the study ranges from 18 February 2020 (epidemic start date in Italy) to 28 May 2020 (3 months). The estimates presented in this paper are based on national epidemiological data, more specifically: 3. The number of PDIs reported by the competent regional authorities to the CNS.

The estimated number of donors who were potentially infected with SARS-CoV-2 was obtained first by calculating the probability that an infected subject in the general population belonging to the 18-69 age bracket, that is, those that include the blood donor population, may have tested positive for SARS-CoV-2.

The cumulative incidence of SARS-CoV-2 positivity, calculated on the general population for each 10-year age bracket, was then applied to the donor population age bracket (18-69). Therefore, the probability values per year of age, taken from the incidence classes of the general population, were recomposed to constitute the age brackets used for donors. In the first two cases, the Transfusion services discarded the donated blood components as an extreme precautionary measure.

The number of clinically recovered donors was calculated using general population data provided by the Ministry of Health. 11 Distribution by age bracket is not available for these individuals, so the total percentage figure on the number of infected individuals was therefore considered. The number of potentially deceased donors was also estimated by applying the same calculation method used for estimating positive donors and on the basis of weekly reports published by the ISS and available online. 10 

As shown in Table 1 , the ISS reports, on which this study was conducted, showed 230 778 positive cases in the general population, 27% of them asymptomatic, and 31 851 deaths distributed by gender and by 10-year age brackets. The number of clinically recovered patients on 28 May 2020, was 147 101 (64% of the total).

The data, obtained from the analysis on the general population, made it possible to estimate 5322 (95% CI: 5187-5460) cases of SARS-CoV-2 expected in the donor population, 3 months after outbreak, against 650 000 active donors in the same quarter of 2019. 7 The calculation of the cumulative incidence of SARS-CoV-2 on the general population, on 26 May 2020, highlighted a greater distribution of positivity in over 69 years of age, that is, those not eligible to donate blood ( Figure 1A ).

The age brackets that include the blood donor population (18-69), highlighted with the pattern filling in Figure 1A , show positivity values that gradually decrease in the younger age brackets.

The cumulative incidence value, calculated for each 10-year age bracket of the general population, was then redistributed to the age brackets of the donor population ( Figure 1B ).

Against the 230 778 positives detected overall in the Italian population, in the 3 months following the outbreak of the epidemic, 134 058, or slightly more than half, belonged to the age brackets of the population that include blood donors and were equally distributed between males and females (64 404 males, 69 654 females).

The results show a higher probability of positivity in the male population, especially for those in the older age brackets. On the contrary, females belonging to the older age brackets have a probability level of positivity very close to that of subjects aged between 26 and 45 years.

For both genders, however, more generally, the estimated probability is lower in the younger age brackets. The linear interpolation method applied to the same data provided overlapping results.

Overall, of these 5322 estimated positive donors, the estimated number of males was 3545 compared to 1777 females. On the whole, the distribution of expected cases shows a greater concentration of positivity in the northern regions (Lombardy, Emilia-Romagna, Piedmont and Veneto) and a decreasing gradient towards central-southern Italy (Figure 2A ).

The distribution of expected cases by gender and age brackets highlights very similar values between males and females for the 18-25 age bracket and with an increase in the male/female ratio in subsequent age brackets ( Figure 2B ). 

The number of donors potentially deceased following SARS-CoV-2 infection was 180. This estimate was arrived at using the same method utilised for the evaluation of infected cases expected in the donor population 3 months after outbreak.

The number of clinically recovered patients in the same period, provided by the Ministry of Health and equal to 147 101, corresponds to 64% of the total infected subjects. Therefore, it is conceivable, that out of 6087 deferred donors, 3652 are theoretically readmitted for donation.

The rapid spread of the SARS-CoV-2 pandemic caused a serious overload for healthcare facilities in numerous countries, with the need to increase the reception capacity in hospitals or even to set up new ones in a very short time.

In the first weeks of the spread of the epidemic, the transfusion system also detected a reduction in blood donations, creating the concern of not being able to satisfy all transfusion requests.

This was followed by numerous initiatives aimed at reducing the consumption of blood components, ensuring the safety of donors and premises and preventing access to subjects at risk of SARS-CoV-2 infection.

In Italy, the response of donors to the appeal launched by the authorities was immediate, and the restoration of blood stocks was achieved in a short time. 7 At the moment, the number of new cases of infection in the national population is on a downward trend, but the proportion of the population susceptible to infection remains very high. 12 There is therefore concern that an epidemic resurgence could also lead to new epidemic peaks in the near future.

By using the institutional surveillance data of the general population and for a defined period of time, the adopted calculation model The projection made, therefore, refers to donors who would not be able to donate because they tested positive for SARS-CoV-2 infection or because they were considered unsuitable on the basis of anamnestic screening or because they were self-excluded.

The positivity data, collected by the ISS and processed in this study, also include a quota of asymptomatic individuals (27%); however, this

is not an exact figure as it does not include any asymptomatic individual not tested for SARS-CoV-2. 13 This category also includes the quota of asymptomatic donors not tested for SARS-CoV-2 who, at least in part, could still be intercepted by the triage or medical selection process that has been put in place in the Italian transfusion system, for example, in the event of close contact with infected individuals.

However, the actual magnitude of asymptomatic subject is currently unknown, and in absence of symptoms or other historical events related to SARS-CoV-2, they will not be deferred from blood donation and could not be included in this forecasting model. which is an average of 650 000 units.

In conclusion, the estimated number of infected donors in the 3-month period examined and considering the worst-case scenario is much lower than the actual reduction in donations in the first

week of the epidemic (10%) 7 and was largely compensated in the following weeks after the appeals to donate blood launched by the competent authorities. The readmission to donate of the previously infected donors could be also considered one of the reasons of this response.

This confirms that, to date, the number of donors infected with SARS-CoV-2 is relatively low and the reduction or increase in donations detected during this outbreak, therefore, is not attributable to the SARS-CoV-2 infection in blood donors but rather to motivations related to donors' fear of contracting the virus or organisational aspects of the transfusion network.

This forecasting model can be a useful tool to obtain information on blood donors involvement both during future SARS-CoV-2 outbreaks, especially in case of changes concerning epidemiology, incidence by age bracket and geographical distribution, and also for new outbreaks of emerging viruses.

World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)

World Health Organisation Statement. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus

the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novelcoronavirus-(2019-ncov)

Impact of Covid-19 on blood centres in Zejiang province China

Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State

Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO)

The blood supply management amid the COVID-19 outbreak

The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy

SARS-CoV-2 transfusion transmitted?

Italian National Institute of Health. COVID-19 outbreak. National update

Characteristics of SARS-CoV-2 patients dying in Italy. Data as of

Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries

A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy

The authors thank Professor Marilyn Scopes (Italian Foundation for Research on Anaemia and Haemoglobinopathies, Genoa, Italy) for her precious assistance with language editing and proofreading.

The authors have no competing interests. Vanessa Piccinini https://orcid.org/0000-0002-3763-0271